Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Dolor informado por el paciente y alivio de los síntomas durante tres meses después de la cirugía por hiperplasia prostática benigna

16 de noviembre de 2026 actualizado por: Joakim Stromberg, Sahlgrenska University Hospital

Dolor y alivio de síntomas informados por el paciente durante tres meses después de la cirugía por hiperplasia prostática benigna.

This is a prospective observational study in patients undergoing surgery for benign prostatic hyperplasia (BPH).

The purpose of the study is to investigate in great detail patients' recovery after surgery for BPH regarding pain, hematuria, urine leakage and use of pain-relieving medications for three months postoperatively. Patient-reported outcomes after three different surgical methods will be investigated: transurethral resection, transurethral vaporization and laser transurethral enucleation of the prostate (Green-LEP)

Research questions:

  • How do patients rate their day-to-day pain during the first three months after surgery for BPH? How long does it take to be pain free?
  • How does the patient estimate any day-to-day burning sensation during the first three months after surgery for BPH?
  • How many painkilling tablets of a certain preparation and a certain strength take patients per day in the first three months after surgery for BPH?
  • How long do patients have urinary leakage after surgery for BPH?
  • Are the patients bothered by possible urine leakage and if so for how long after surgery for BPH?
  • How long does one have macroscopic hematuria after surgery for BPH?
  • How quickly are the patients' urinary tract problems affected according to the IPSS per month?
  • Are the results on the above outcome measures different between the three TUR-P methods, TUV-P and Green LEP?

Descripción general del estudio

Descripción detallada

Design and selection:

This is a prospective multicenter observational study in which patients undergoing TUR-P, TUV-P and GreenLEP for BPH are included. The subjects will be followed up with a self-assessment form that is completed daily for three months and then sent to the responsible researchers. After this, the research subjects will be followed up with sent out IPSS forms after six months, and then annually for up to five years. These are sent in stamped envelopes.

Participants:

The study will include 500 patients who undergo surgery for BPH at Alingsås hospital, Sjukhusen i Väster and Sahlgrenska University Hospital, as well as possibly an additional urology clinic in the future. The inclusion criteria include men over 50 years of age with diagnosed BPH and LUTS who have an indication for surgery with any of the three methods studied.

Outcome measures:

  1. Pain and burning will be assessed using the NRS (numeric scale) between 0 and 10 where 0 is defined as "no pain/burning" and 10 is defined as "worst imaginable pain/burning". The researchers fill in this day-by-day for three months
  2. Use of pain-relieving medications will be investigated with a table in which the research subjects enter drug names and sum up the number of tablets taken per day.
  3. Urine leakage will be examined by the research subjects checking either "Yes" or "no" on the question of whether they have had urine leakage on a daily basis.
  4. If this urine leakage has bothered the research subjects, it is investigated by ticking either "Yes" or "No" daily as a follow-up question to the previous one.
  5. The duration of hematuria will be examined by the research subjects checking either "Yes" or "No" on the question of whether they have had blood in the urine daily
  6. The change in LUTS measured by IPSS will be used to measure patient-perceived outcomes at baseline, after four, eight and twelve weeks, after six months and then annually for five years.

Data Analysis:

Descriptive statistics will be used to compile the PROMs data. Changes over time will be analyzed using repeated measures (ANOVA). Differences in outcome measures between the three different methods will be analyzed with the Mann-Whitney test for continuous, independent data pairs, and the Chi-Square test for categorical variables.

Ethical considerations:

The study will be conducted in accordance with the Declaration of Helsinki, and all participants will give their informed consent. Ethical approval will be sought from the Ethical Review Authority (EPM)

Significance and clinical relevance:

The results of this study will provide important insights into how patient-reported outcomes after benign prostate surgery can be used to improve surgical outcomes and patient counseling. The results will also be able to be used to compare outcome measures between the three different treatments used for BPH. By highlighting the patient's perspective, care can be developed to better meet the patients' needs and expectations, and by determining a "normal course" regarding these outcome measures, the results can also be used in the future to identify patients who deviate from the expected recovery course.

Tipo de estudio

De observación

Inscripción (Estimado)

500

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Ubicaciones de estudio

      • Alingsås, Suecia
        • Reclutamiento
        • Alingsås lasarett, department of general surgery, urology and orthopaedic surgery
      • Uddevalla, Suecia
        • Aún no reclutando
        • NU sjukvården, Uddevalla sjukhus, department of urology
    • Sweden
      • Kungälv, Sweden, Suecia
        • Aún no reclutando
        • Kungälvs sjukhus, department of urology

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

50 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Masculino

Método de muestreo

Muestra no probabilística

Población de estudio

Patients scheduled for surgery for benign prostatic hyperplasia

Descripción

Inclusion Criteria:

  • Patients undergoing transurethral surgery for benign prostatic hyperplasia
  • Singed informed consent to participate

Exclusion Criteria:

  • Non-swedish speaking patients

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Modelos observacionales: COHORT
  • Perspectivas temporales: PROSPECTIVE

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
Patient treated by transurethral surgical procedure

Patients treated for BPH with surgery

Thermocoagulation is used in contrast to the other methods

Heat is used to vaporize prostate

laser is used in contrast to the other methods

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in postoperative pain levels
Periodo de tiempo: Day-by-day for three months

Day-by-day registration of pain by NRS (numeric response scale) for pain. Anchorpoints: 0 (no pain) to 10 (worst possible pain)

Day-by-day for three months

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Use of analgesics postoperatively
Periodo de tiempo: Day-by-day for three months

Patients are to report all pain medication used day-by-day

Day-by-day for three months
Duration of postoperative hematuria
Periodo de tiempo: Day-by-day for three months

The patients register the incidence of hematuria day-by-day by checking either "yes" or "no"

Day-by-day for three months
Duration of postoperative leakage of urine
Periodo de tiempo: Day-by-day for three months

The patients record the incidence of leakage of urine day-by-day by checking either "yes" or "no" box

Day-by-day for three months
Concerns about urine leakage
Periodo de tiempo: Day-by-day for three months

If the patients have checked the box "yes" for urine leakage, they are asked to record if they are bothered by this leakage or not by checking either "yes" or "no" box

Day-by-day for three months
Changes in Lower Urinary Tract Symptoms as measured by the IPSS questionnaire
Periodo de tiempo: Month-by-month for 3 months

The patients are asked to complete the IPSS (International Prostatic Symptom Score) once a month. The IPSS is made up of 7 questions related to voiding symptoms. A score of 0 to 7 indicates mild symptoms, 8 to 19 indicates moderate symptoms and 20 to 35 indicates severe symptoms.

Month-by-month for 3 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Colaboradores

Investigadores

  • Investigador principal: Joakim BE Strömberg, MD, PhD, Sahlgrenska University Hospital

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

15 de marzo de 2025

Finalización primaria (Estimado)

31 de enero de 2027

Finalización del estudio (Estimado)

31 de enero de 2027

Fechas de registro del estudio

Enviado por primera vez

21 de febrero de 2025

Primero enviado que cumplió con los criterios de control de calidad

27 de febrero de 2025

Publicado por primera vez (Actual)

28 de febrero de 2025

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

17 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

16 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir